From owner-chemistry: at :ccl.net Thu Nov 17 21:09:01 2011 From: "Jan Labanowski janl-x-speakeasy.net" To: CCL Subject: CCL: Therapeutic applications of computational chemistry and biology (TACBAC) Message-Id: <-45896-111117210735-369-y2RAov7lXznk/RfsddWfXw * server.ccl.net> X-Original-From: Jan Labanowski Content-Disposition: inline Content-Transfer-Encoding: 8bit Content-Type: text/plain; charset="iso-8859-1" Date: Thu, 17 Nov 2011 21:07:27 EST MIME-Version: 1.0 Sent to CCL by: Jan Labanowski [janl^speakeasy.net] Subject: Fwd: Therapeutic applications of computational chemistry and biology (TACBAC) Wellcome Trust meeting on Therapeutic applications of computational chemistry and biology (TACBAC) WT Conference Centre, near Cambridge (UK) 12-14 March 2012 https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=263 The conference will take place at the WT Conference Centre, near Cambridge (UK) on the 12-14 March 2012. This conference will bring together leading researchers investigating computational chemistry and biology techniques as applied to advancing our ability to predict, diagnose and modulate human disease. This broad and multidisciplinary meeting will explore the major challenges in drug discovery and development where innovation in computational approaches and tools can really make a significant and tangible contribution towards novel treatments. Each of the sessions, which progress from identifying disease mechanisms to implementing new therapeutic and diagnostic approaches in the clinic, will bring together experts in both the biomedical and the computational aspects of the topic under discussion. Session topics * Clinical implications of individual genomes * Metabolism and biomarkers * Computational systems biology * Discovery of chemical probes * Modelling xenobiotic metabolism Scientific Programme Committee: Lee Harland, Pfizer, UK John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK Speakers include: Chas Bountra, Structural Genomics Consortium, UK Paul Flicek, EMBL-European Bioinformatics Institute, Hinxton, UK Ronald Frank, Helmholtz Centre for Infection Research, Germany Bobby Glen, University of Cambridge, UK Roy Goodacre, University of Manchester, UK Jules Griffin, University of Cambridge, UK Lee Harland, Pfizer, UK Aroon Hingorani, University College London, UK John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK Julio Saez-Rodriguez, EMBL-European Bioinformatics Institute, Hinxton, UK Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK Olivier Tabourieau, Center for Biological Sequence Analysis, Denmark For more details, please view the the conference website: https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=263